Product Recalls in New Hampshire

Product recalls affecting New Hampshire — including food, drugs, consumer products, medical devices, and vehicles distributed to New Hampshire. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,579 recalls have been distributed to New Hampshire in the last 12 months.

49,311 total recalls
2,579 in last 12 months

Showing 15211540 of 13,374 recalls

DrugAugust 9, 2023· Ecometics, Inc.

Recalled Item: Unguentine Ointment Recalled by Ecometics, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Products not manufactured under current good manufacturing...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 9, 2023· Ecometics, Inc.

Recalled Item: YAGER'S LINIMENT (Camphor and Turpentine Oil) 3.1% and 8.12% respectively...

The Issue: CGMP Deviations: Products not manufactured under current good manufacturing...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 7, 2023· Advanced Accelerator Applications USA, Inc.

Recalled Item: PLUVICTO 1 Recalled by Advanced Accelerator Applications USA, Inc. Due to...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugAugust 3, 2023· APG SEVEN, INC

Recalled Item: Vegetal Vigra Recalled by APG SEVEN, INC Due to Marketed Without an Approved...

The Issue: Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugAugust 2, 2023· Aurobindo Pharma USA Inc.

Recalled Item: Rasagiline Tablets 0.5mg Recalled by Aurobindo Pharma USA Inc. Due to Failed...

The Issue: Failed dissolution specifications - results obtained were below spec average.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 2, 2023· Parker Laboratories, Inc.

Recalled Item: Helix Pain Relieving Cream (Menthol 7.4%) Recalled by Parker Laboratories,...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 2, 2023· Parker Laboratories, Inc.

Recalled Item: Helix Tri-Active Therapy Cream (Camphor 3.2% Recalled by Parker...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 2, 2023· Parker Laboratories, Inc.

Recalled Item: Helix CBD Therapy Cream (Menthol 7.4%) Recalled by Parker Laboratories, Inc....

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 2, 2023· Parker Laboratories, Inc.

Recalled Item: Helix CBD Clinical Cream (Menthol 7.4%) Recalled by Parker Laboratories,...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 2, 2023· Parker Laboratories, Inc.

Recalled Item: Protex Foaming Hand Sanitizer (Benzalkonium Chloride 0.13%) Recalled by...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 27, 2023· ALEMBIC PHARMACEUTICALS, INC.

Recalled Item: Tobramycin Opthalmic Solution USP Recalled by ALEMBIC PHARMACEUTICALS, INC....

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 21, 2023· The Ritedose Corporation

Recalled Item: Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL 96 Plastic Recalled...

The Issue: CGMP deviation: product released prior to supplier approval.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 21, 2023· Aurobindo Pharma USA Inc.

Recalled Item: Rufinamide Tablets Recalled by Aurobindo Pharma USA Inc. Due to cGMP...

The Issue: cGMP deviations: Batch was released prior to approval.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 21, 2023· Aurobindo Pharma USA Inc.

Recalled Item: Rufinamide Tablets Recalled by Aurobindo Pharma USA Inc. Due to cGMP...

The Issue: cGMP deviations: Batch was released prior to approval.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 18, 2023· Ascend Laboratories, LLC

Recalled Item: Fosfomycin Tromethamine Granules for Oral Solution Recalled by Ascend...

The Issue: Failed Impurities/Degradation Specifications: Out-of-specification results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 18, 2023· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Dofetilide Capsules 500 mcg (0.5mg) Recalled by SUN PHARMACEUTICAL...

The Issue: Out of Specification result observed in content uniformity testing

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJuly 17, 2023· Central Admixture Pharmacy Services Inc

Recalled Item: succinylcholine Recalled by Central Admixture Pharmacy Services Inc Due to...

The Issue: Lack of assurance of sterility: Lack of validation data for sanitization cycles

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 17, 2023· Central Admixture Pharmacy Services Inc

Recalled Item: morphine in 0.9% sodium chloride Recalled by Central Admixture Pharmacy...

The Issue: Lack of assurance of sterility: Lack of validation data for sanitization cycles

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 17, 2023· Central Admixture Pharmacy Services Inc

Recalled Item: HYDROmorphone in 0.9% sodium chloride Recalled by Central Admixture Pharmacy...

The Issue: Lack of assurance of sterility: Lack of validation data for sanitization cycles

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJuly 17, 2023· Central Admixture Pharmacy Services Inc

Recalled Item: morphine in 0.9% sodium chloride Recalled by Central Admixture Pharmacy...

The Issue: Lack of assurance of sterility: Lack of validation data for sanitization cycles

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund